Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.
about
Novel viral vectored vaccines for the prevention of influenza.Peste des petits ruminants virus infection of small ruminants: a comprehensive review.Canine recombinant adenovirus vector induces an immunogenicity-related gene expression profile in skin-migrated CD11b⁺ -type DCs.The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.Modified vaccinia virus Ankara-based vaccine vectors induce apoptosis in dendritic cells draining from the skin via both the extrinsic and intrinsic caspase pathways, preventing efficient antigen presentation.Increasing vaccine potency through exosome antigen targeting.Immunogenicity of targeted lentivectors.Subset-Specific Expression of Toll-Like Receptors by Bovine Afferent Lymph Dendritic Cells.Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.Clinical applications of attenuated MVA poxvirus strain.Improving T cell-induced response to subunit vaccines: opportunities for a proteomic systems approach.Global Foot-and-Mouth Disease Research Update and Gap Analysis: 6 - Immunology.Transduction of skin-migrating dendritic cells by human adenovirus 5 occurs via an actin-dependent phagocytic pathway.Bovine γδ T cells are a major regulatory T cell subset.Recombinant adenovirus expressing the haemagglutinin of Peste des petits ruminants virus (PPRV) protects goats against challenge with pathogenic virus; a DIVA vaccine for PPR.The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes.
P2860
Q30418570-E342A72E-7DFA-4453-8343-7EF1B27643E9Q33820705-18E705FE-8172-4BC2-8F7A-4F8C39DEF20BQ34540809-217A74C6-759A-4C1D-880E-801FCB07C780Q35091556-42774E5F-B764-40F2-8446-893CBC927EE4Q35943471-24DB9918-97AF-4B77-93FA-BF3220AB35FBQ35955224-7A0C9FA1-3C94-4227-873F-9EFB0BC09BB9Q37718447-66605952-033C-44A6-83E3-8CCB34F113D7Q37733758-5461CFE4-D7F3-4937-8C30-9DA19183A9FBQ38096489-4214BD7C-9F68-4B7B-9C6F-939A59BEFF7CQ38156198-5DB10661-FA7A-4B2A-B717-6BBE7AC46E41Q38364597-AD8FA21E-91A3-41F2-A35D-6C8E7582C0A9Q38851205-2647DB51-90B2-46E0-9337-6A106B8272A5Q40574579-1BA1F0FD-FAE1-4708-9230-9B570792C4FFQ40963680-05F51560-83C8-42E3-BB08-C7B1893F5E4AQ41995734-FD54CE02-4703-4410-9630-CEA77F703944Q48101757-D7E3C11A-DD87-4A63-8A5A-D2CE10E40976
P2860
Differential effects of viral vectors on migratory afferent lymph dendritic cells in vitro predict enhanced immunogenicity in vivo.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Differential effects of viral ...... hanced immunogenicity in vivo.
@ast
Differential effects of viral ...... hanced immunogenicity in vivo.
@en
type
label
Differential effects of viral ...... hanced immunogenicity in vivo.
@ast
Differential effects of viral ...... hanced immunogenicity in vivo.
@en
prefLabel
Differential effects of viral ...... hanced immunogenicity in vivo.
@ast
Differential effects of viral ...... hanced immunogenicity in vivo.
@en
P2093
P2860
P50
P356
P1433
P1476
Differential effects of viral ...... nhanced immunogenicity in vivo
@en
P2093
C Cubillos-Zapata
H Prentice
P2860
P304
P356
10.1128/JVI.05127-11
P407
P577
2011-07-13T00:00:00Z